News

BioNitrogen Corporation (Pink Sheets:BION) a developer of revolutionary patent-pending technology for converting renewable and abundant biomass waste into high-nitrogen urea and urea fertilizer has finalized and executed a revised agreement with Agricultural Bioenergy Products, LLC (ABP) and BIO-SNG Technologies International, LLC, a wholly owned subsidiary of BioNitrogen. In yet another important agreement for BioNitrogen, the Company today announced an exclusive agreement that extends the Patent Cooperation Treaty Application No. PCT/US2009/053547, Modularized System and Method for Urea Production using a Bio-mass Feedstock exclusively to BioNitrogen. The U.S. Patent filing involves a proprietary process for the conversion of biomass into Urea Fertilizer. BioNitrogen's President & CEO, Carlos A. Contreras offers his perspective of this important agreement, "Today BioNitrogen continued to build a dynamic future for our employees and shareholders. In yet another continuation of recent business development agreements, this particular agreement will result in worldwide urea production as the company now controls the exclusivity to this amazing proprietary conversion technology. This agreement also allows BioNitrogen to further sub-license this proprietary conversion technology to other entities and strategic partners to build plants and produce urea worldwide. In addition, this revised agreement eliminates the up-front fee to ABP as contained in the prior agreement, thus allowing BioNitrogen to utilize its resources in developing its business model."

Gevo, Inc., a renewable chemicals and next-generation biofuels company, signed a Joint Development Agreement (JDA) with Beta Renewables, a joint venture between Chemtex and TPG, to develop an integrated process for the production of bio-based isobutanol from cellulosic, non-food biomass.

The Evonik Executive Board has approved the realization of the project, based in Volgodonsk in Russia's Rostov region. The DonBioTech joint venture will now go ahead with the construction of a Biolys® manufacturing plant in Volgodonsk. The facility is scheduled to go on stream in 2014 with a capacity of around 100,000 metric tons of Biolys®. Evonik, which is holding a minority share, and the Russian Varshavsky Group are the operative partners in the joint venture. Furthermore, JSC Russian Agricultural Bank is interested in participating in the financing of the project

Evonik Industries and Russian company RusBiotech International have established the joint venture Russkie Biotechnologii for manufacturing L-lysine in Russia by means of a biotechnological process. Vassily Golubev, governor of the Rostov-on-Don region, and Vadim Varshavsky, a deputy of the State Duma of the Russian Federation, supported the formation of the joint venture. The purpose of this joint venture, in which Evonik holds a minority shareholding with an option to increase its share significantly, is to produce the feed amino acid L-lysine in Russia.